Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOP | Modern Pathology
Relapsed or Refractory Diffuse Large B-Cell Lymphoma: “Dazed and Confused”
Course of therapy, responses and outcomes. DLBCL, diffuse large B-cell... | Download Scientific Diagram
Diffuse Large B cell lymphoma (DLBCL) - Lymphoma Australia
Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trial - The Lancet Haematology
Novel treatments in B cell non-Hodgkin's lymphomas | The BMJ
Biology Informs Treatment Choices in Diffuse Large B Cell Lymphoma: Trends in Cancer
Factors related to the relative survival of patients with diffuse large B-cell lymphoma in a population-based study in France: does socio-economic status have a role? | Haematologica
New Approaches to the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma
Cancers | Free Full-Text | Monoclonal Antibodies in the Treatment of Diffuse Large B-Cell Lymphoma: Moving beyond Rituximab